Clinical trial
CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal…
NCT00087074 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00087074 |
|---|---|
| Title | CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor |
| Official title | A Trial of CCI-779 in Patients With Soft Tissue Sarcoma. |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastrointestinal Stromal Tumor, Recurrent Adult Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma |
| Intervention type | Drug, Other |
| Interventions | temsirolimus, laboratory biomarker analysis |
| Enrollment | 55 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2005 |
| First posted | Jul 12, 2004 |
| Last update posted | Jun 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: